Esters-buliding-blocks

On May 13, 2004, Jones, Peter; Burli, Roland W.; Jiang, Chun; McMinn, Dustin L. published a patent.Category: esters-buliding-blocks The title of the patent was Preparation of arylcarbonylaminopyrrolylcarbonylaminopyrrolylbenzimidazoles and related compounds as antiinfectives.. And the patent contained the following:

Title compounds [I; Ar = (substituted) (fused) Ph, heteroaryl; Q = N, CH, CR6; ≤2 Q = N; R1-R4 = H, alkyl; R5 = H, (substituted) alkyl, heteroalkyl; R6 = (substituted) alkyl, OR5, N(R5)2, O2CR5, NCOR5, Cl, F, Br], were prepared Thus, title compound (II) (preparation given) showed a min. inhibitory concentration of ≤4 μg/mL against Staphylococcus aureus 33591. The experimental process involved the reaction of tert-Butyl (4-hydroxy-2-nitrophenyl)carbamate(cas: 201811-20-3).Category: esters-buliding-blocks

The Article related to arylcarbonylaminopyrrolylcarbonylaminopyrrolylbenzimidazole preparation antibacterial, benzimidazole arylcarbonylaminopyrrolylcarbonylaminopyrrolyl preparation antibacterial, pyrrolylcarbamoylpyrrole arylaminocarbonyl imidazoazine preparation antiinfective and other aspects.Category: esters-buliding-blocks

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On August 10, 2021, Moriyama, Akihiro; Kawabe, Yusuke; Otsuki, Shinobu; Takikawa, Yasushi published a patent.Computed Properties of 1198284-94-4 The title of the patent was Preparation of (hetero)arylimidazolone compounds as inhibitors of prolyl hydroxylases (PHDs). And the patent contained the following:

The (hetero)arylimidazolone compounds represented by the following formula I [m, u = independently 0, 1, 2, or 3; p, q = independently 1 or 2; r = an integer from 0 to 6; R1 = halo, C1-6 alkyl, cyano, hydroxy, or carboxy (m = 2 or 3, two or more R1s may be different from each other); E, G, Q, T are groups selected from the group consisting of the following (1) to (7): (1) E = CR2e, Q = CR2q, T = CR2t, G = N; (2) E = CR2e, G = CR2g, T = CR2t, Q = N; (3) E = CR2e, G = CR2g, Q = CR2q, T = N; (4) E = CR2e, Q = CR2q, G = T = N, (5) G = CR2g, T = CR2t, E = Q = N; (6) G = CR2g, Q = CR2q, E = T = N; and (7) E = CR2e, G = CR2g, Q = CR2q, T = CR2t; R2e, R2g, R2q, R2t = independently H, halogen, C1-6 alkyl, Halo-C1-6 alkyl, C1-6 alkoxy, halo-C1-6 alkoxy, hydroxy, CO2H, C1-6 alkoxycarbonyl, or (un)substituted NH2; ring W = C6-10 aryl, 5- or 6-membered ring heteroaryl, 9 or 10-membered ring heteroaryl, C3-8 cycloalkyl, or 3- to 8-membered heterocycloalkyl; ring Z = Q1, Q2, or Q3; Ra, Rb, Rc = independently H, halogen, C1-6 alkyl, cyano, Hydroxy, or carboxy; Rd = H or C1-6 alkyl; R3 = halogen, C1-6 alkyl, halo-C1-6 alkyl, C1-6 alkoxy, halo-C1-6 alkoxy, C2-6 alkoxy, C2-6 alkynyl, C1-6 alkylsulfanyl, C1-6 alkylsulfinyl, C1-6 alkoxysulfonyl, hydroxy, cyano, nitro, CO2H, C1-6 alkoxycarbonyl, or each (un)substituted or CONH2, etc.] or pharmacol. acceptable salts thereof. The compounds I or pharmacol. acceptable salts thereof have an inhibitory action on prolyl hydroxylases (PHDs) and are useful as therapeutic agents for inflammatory bowel disease such as ulcerative colitis and Crohn’s disease. Thus, (S)-3-[3-[6-[4-(methoxycarbonyl)phenyl]pyridin-3-yl]-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl]pyrrolidine-1-carboxylic acid tert-Bu ester was treated with 4 M HCl/1,4-dioxane solution at room temperature for 8 h to give (S)-3-[3-[6-[4-(methoxycarbonyl)phenyl]pyridin-3-yl]-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl]pyrrolidine which underwent reductive alkylation with 2-formylisonicotinic acid Me ester using NaBH(OAc)2 in the presence of Et3N in THF at room temperature for 2 h to give (S)-2-[[3-[3-[6-[4-(methoxycarbonyl)phenyl]pyridin-3-yl]-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl]pyrrolidin-1-yl]methyl]isonicotinic acid Me ester (II; R = Me). II (R = Me) was stirred with LiOH in aqueous methanol at 65° for 1 h, cooled to room temperature, treated with concentrated HCl, and stirred at 50° for 30 min to give (S)-2-[[3-[3-[6-(4-Carboxyphenyl)pyridin-3-yl]-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl]pyrrolidin-1-yl]methyl]isonicotinic acid II (R = H). II (R = H) showed IC50 of 0.12μM against human PHD2184-418. The experimental process involved the reaction of tert-Butyl 1-oxo-2,9-diazaspiro[5.5]undecane-9-carboxylate(cas: 1198284-94-4).Computed Properties of 1198284-94-4

The Article related to heteroarylimidazolone preparation inhibitor prolyl hydroxylases phd, arylimidazolone preparation inhibitor prolyl hydroxylase phd, inflammatory bowel disease treatment imidazolone preparation, ulcerative colitis crohn disease treatment imidazolone preparation and other aspects.Computed Properties of 1198284-94-4

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Solansky, Martin; Mikulasek, Kamil; Zapletalova, Martina; Petrivalsky, Marek; Chiltz, Annick; Zdrahal, Zbynek; Leborgne-Castel, Nathalie; Lochman, Jan published an article in 2021, the title of the article was The oligomeric states of elicitins affect the hypersensitive response and resistance in tobacco.Synthetic Route of 79642-50-5 And the article contains the following content:

Successful plant defense against microbial pathogens is based on early recognition and fast activation of inducible responses. Key mechanisms include detection of microbe-associated mol. patterns by membrane-localized pattern recognition receptors that induce a basal resistance response. A well-described model of such responses to pathogens involves the interactions between Solanaceae plants and proteinaceous elicitors secreted by oomycetes, called elicitins. It has been hypothesized that the formation of oligomeric structures by elicitins could be involved in their recognition and activation of defensive transduction cascades. In this study, we tested this hypothesis using several approaches, and we observed differences in tobacco plant responses induced by the elicitin β-cryptogein (β-CRY) and its homodimer, β-CRYDIM. We also found that the C-terminal domain of elicitins of other ELI (true-elicitin) clades plays a significant role in stabilization of their oligomeric structure and restraint in the cell wall. In addition, covalently crosslinking β-CRYDIM impaired the formation of signalling complexes, thereby reducing its capacity to elicit the hypersensitive response and resistance in the host plant, with no significant changes in pathogenesis-related protein expression. By revealing the details of the effects of β-CRY dimerization on recognition and defense responses in tobacco, our results shed light on the poorly understood role of elicitins′ oligomeric structures in the interactions between oomycetes and plants. The experimental process involved the reaction of Bis(2,5-dioxopyrrolidin-1-yl) glutarate(cas: 79642-50-5).Synthetic Route of 79642-50-5

The Article related to oligomeric elicitin beta cryptogein hypersensitive response tobacco, nicotiana tabacum , phytophthora , cell wall, elicitin response, suppressor of bir1-1 (sobir1), elicitin β-cry, hypersensitive response, oligomeric structure, resistance, signalling, tobacco and other aspects.Synthetic Route of 79642-50-5

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On May 18, 2018, Wang, Xiuqin; Feng, Juanjuan; Tian, Yu; Luo, Chuannan; Sun, Min published an article.HPLC of Formula: 118-55-8 The title of the article was Co-Al bimetallic hydroxide nanocomposites coating for online in-tube solid-phase microextraction. And the article contained the following:

The Co-Al bimetallic hydroxide nanocomposites were synthesized and used as in-tube solid-phase microextraction coating. The nanocomposites-coated fibers were packed in a PEEK tube and tested for the extraction of eight polycyclic aromatic hydrocarbons (PAHs) coupled with high performance liquid chromatog. Several parameters affecting the PAHs extraction including the sampling volume, sampling flow rate, methanol content and desorption time were investigated. Under the optimized conditions, the extraction tube with nanocomposites coating exhibited remarkable extraction performance towards PAH targets. An online anal. method was achieved with the limits of detection less than 0.02 μg L-1 and the linearity in the range from 0.03 to 15 μg L-1. The recoveries of the method for two water samples with spiking levels of 1 and 10 μg L-1 ranged from 83 to 121%. Extraction repeatability and preparation repeatability were less than 4.0% and 10.9%, resp. The experimental process involved the reaction of Phenyl Salicylate(cas: 118-55-8).HPLC of Formula: 118-55-8

The Article related to cobalt aluminum hydroxide coating microextraction polycyclic aromatic hydrocarbon water, co-al bimetallic hydroxide, high performance liquid chromatography, nanocomposites coating, online analysis, polycyclic aromatic hydrocarbons, solid-phase microextraction and other aspects.HPLC of Formula: 118-55-8

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On August 15, 2020, Guo, Yujing; Pei, Chao; Koenigs, Rene M. published an article.Product Details of 2873-29-2 The title of the article was Substrate-Controlled Cyclopropanation Reactions of Glycals with Aryl Diazoacetates. And the article contained the following:

Cyclopropanation reactions of D-glucal and D-galactal derivatives with aryldiazoacetates can be conducted in a substrate-controlled, stereoselective fashion using simple Rh(II) catalysts, which is further supported by DFT studies. Following this methodol., sugar-derived, donor-acceptor cyclopropanes can be accessed that allow stereoselective O-glycosylation reactions. The experimental process involved the reaction of (2R,3S,4R)-2-(Acetoxymethyl)-3,4-dihydro-2H-pyran-3,4-diyl diacetate(cas: 2873-29-2).Product Details of 2873-29-2

The Article related to transition state cyclopropanation glucal diazoalkane dft aryl diazoacetate, rhodium catalyst cyclopropane stereoselective glycosylation glycoside carboxylate preparation, stereoselective glycosylation cyclopropanation galactal aryldiazoacetate glucal catalyst and other aspects.Product Details of 2873-29-2

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On July 31, 2022, Saima, Yasmin; Khamarui, Saikat published an article.Formula: C12H16O7 The title of the article was MnVI-NP-Catalyzed Generation of Nitrile Oxides: Easy Access to Isoxazolines and Isoxazoles via Stereoselective 1,3-Dipolar Cycloaddition Reactions. And the article contained the following:

The versatility and effectiveness of Mn(VI)-nanoparticles as a catalyst is examined for the generation of nitrile oxides from aldoximes and subsequent 1,3-dipolar cycloaddition reactions. This synthetic protocol features fast reaction convergence under benign reaction conditions, operational simplicity, and the use of inexpensive precursors; it avoids the use of acids or bases. The strategy offers excellent chemo-, regio-, and diastereoselectivity in the 1,3-dipolar cycloaddition reaction of in situ-generated nitrile oxides with alkenes and alkynes. The experimental process involved the reaction of (2R,3S,4R)-2-(Acetoxymethyl)-3,4-dihydro-2H-pyran-3,4-diyl diacetate(cas: 2873-29-2).Formula: C12H16O7

The Article related to aldoxime alkene manganese catalyst chemoselective regioselective diastereoselective dipolar cycloaddition, isoxazole preparation, alkyne aldoxime manganese catalyst chemoselective regioselective diastereoselective dipolar cycloaddition, isoxazoline preparation and other aspects.Formula: C12H16O7

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On June 6, 2013, Steeneck, Christoph; Kinzel, Olaf; Gege, Christian; Kleymann, Gerald; Hoffmann, Thomas published a patent.HPLC of Formula: 93476-46-1 The title of the patent was Preparation of pyrrolocarboxamides as modulators of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases. And the patent contained the following:

The invention provides modulators for the orphan nuclear receptor RORγ and methods for treating RORγ mediated diseases by administrating these novel RORγ modulators to a human or a mammal in need thereof. Specifically, the present invention provides pyrrolocarboxamide compounds I [R1 = H, alkyl, cycloalkyl, etc.; R2 = H, alkyl, haloalkyl, hydroxyalkyl; or NR1R2 = (un)substituted 3-8 membered ring containing carbon atoms and optionally containing 1-2 heteroatoms selected from O, S and N; R3 = (un)substituted pyridinone, 6-10 membered mono- or bicyclic aryl, 5-10 membered mono- or bicyclic heteroaryl containing 1-4 heteroatoms selected from N, O or S, etc.; R4 = SO2(CR8R8)yR7, SO2NR12R7, (CR8R8)xR10 or cycloalkyl, which is spirocyclic fused with cycloalkyl; R5 = H, alkyl, haloalkyl, etc.; R6 = H, alkyl, haloalkyl, halo; R7 = (un)substituted cycloalkyl, heterocycloalkyl; R8 = H, F, alkyl, haloalkyl, OH; R10 = (un)substituted cycloalkyl; R12 = H, alkyl, haloalkyl; x = 1-2; y = 0-2; with the proviso] and the enantiomers, diastereomers, N-oxides, tautomers, solvates and pharmaceutically acceptable salts thereof. Over six hundred compounds I were prepared E.g., a multi-step synthesis of II, starting from 1-cyclohexylethanol, was described. Exemplified compounds I were tested in RORγ GaI4 reporter gene assay (data given). Pharmaceutical composition comprising compound I was disclosed. The experimental process involved the reaction of Ethyl indolizine-1-carboxylate(cas: 93476-46-1).HPLC of Formula: 93476-46-1

The Article related to pyrrolocarboxamide preparation orphan nuclear receptor rar related gamma modulator, retinoid related orphan receptor gamma modulator pyrrolocarboxamide preparation antiinflammatory, autoimmune disease treatment pyrrolocarboxamide preparation ror gamma modulator and other aspects.HPLC of Formula: 93476-46-1

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On August 31, 2020, Thakur, Kratima; Khare, Naveen K. published an article.Quality Control of (2R,3S,4R)-2-(Acetoxymethyl)-3,4-dihydro-2H-pyran-3,4-diyl diacetate The title of the article was Copper mediated A3-coupling reaction for the preparation of enantioselective deoxy sugar based chiral propargylamine using bifunctional ligand L-proline. And the article contained the following:

An efficient three component coupling of aromatic aldehyde, deoxy sugar based alkyne (α-2-deoxy propargyl glycoside) and heterocyclic amine have been refluxed to synthesize stereoselective chiral propargylamine with good to excellent yield using only CuI catalyst along with bifunctional ligand L-proline. This method has proved to be applicable in wide range of substrates and found highly enantioselective with respect to earlier reported methods. In addition, L-proline was found as a chiral source which demonstrated that it could be developed as a highly enantioselective method for the construction of deoxy sugar based chiral propargylamine. The ligand L-proline was used for the first time in enantioselective A3-coupling reaction of α-2-deoxy propargyl glycosides involving substituted aromatic aldehyde and heterocyclic amines. Herein, we have synthesized 15 novel compounds based on A3-coupling reaction and structures of all the enantioselective compounds were characterized by TLC and NMR spectroscopy. The experimental process involved the reaction of (2R,3S,4R)-2-(Acetoxymethyl)-3,4-dihydro-2H-pyran-3,4-diyl diacetate(cas: 2873-29-2).Quality Control of (2R,3S,4R)-2-(Acetoxymethyl)-3,4-dihydro-2H-pyran-3,4-diyl diacetate

The Article related to glycoside propargylamine proline copper catalyst coupling preparation aldehyde, copper catalyst coupling preparation enantioselective deoxy sugar propargylamine proline, a(3)-coupling reaction, c–h bond activation, enantioselectivity, propargylamines, l-proline and other aspects.Quality Control of (2R,3S,4R)-2-(Acetoxymethyl)-3,4-dihydro-2H-pyran-3,4-diyl diacetate

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Joumaa, Ahmad; Gayet, Florence; Garcia-Suarez, Eduardo J.; Himmelstrup, Jonas; Riisager, Anders; Poli, Rinaldo; Manoury, Eric published an article in 2020, the title of the article was Synthesis of nixantphos core-functionalized amphiphilic nanoreactors and application to rhodium-catalyzed aqueous biphasic 1-octene hydroformylation.Formula: C12H18O5 And the article contains the following content:

A latex of amphiphilic star polymer particles, functionalized in the hydrophobic core with nixantphos and containing P(MAA-co-PEOMA) linear chains in the hydrophilic shell (nixantphos-functionalized core-crosslinked micelles, or nixantphos@CCM), has been prepared in a one-pot three-step convergent synthesis using reversible addition-fragmentation chain transfer (RAFT) polymerization in water. The synthesis involves polymerization-induced self-assembly (PISA) in the second step and chain crosslinking with di(ethylene glycol) dimethacrylate (DEGDMA) in the final step. The core consists of a functionalized polystyrene, obtained by incorporation of a new nixantphos-functionalized styrene monomer (nixantphos-styrene), which is limited to 1 mol%. The nixantphos-styrene monomer was synthesized in one step by nucleophilic substitution of the chloride of 4-chloromethylstyrene by deprotonated nixantphos in DMF at 60°C, without interference of either phosphine attack or self-induced styrene polymerization The polymer particles, after loading with the [Rh(acac)(CO)2] precatalyst to yield Rh-nixantphos@CCM, function as catalytic nanoreactors under aqueous biphasic conditions for the hydroformylation of 1-octene to yield n-nonanal selectively, with no significant amounts of the branched product 2-methyl-octanal. The experimental process involved the reaction of Oxybis(ethane-2,1-diyl) bis(2-methylacrylate)(cas: 2358-84-1).Formula: C12H18O5

The Article related to octene nixantphos rhodium catalyzed core functionalized amphiphilic nanoreactor hydroformylation, raft polymerization, aqueous biphasic catalysis, hydroformylation, nixantphos, polymerization-induced self-assembly, rhodium, water-confined polymeric nanoreactors and other aspects.Formula: C12H18O5

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On June 15, 2000, Hewawasam, Piyasena; Starrett, John E., Jr. published a patent.Related Products of 141940-37-6 The title of the patent was Preparation of 3-substituted-4-arylquinolin-2-one derivatives as calcium-activated potassium (BK) channel openers. And the patent contained the following:

The title compounds (I) [wherein R and R1 = independently H or Me; R2, R3, and R4 = independently H, halogen, NO2, or CF3; R5 = Br, Cl, or NO2; R6 = H or F; R7 = Me, CRR1OH, CHO, C:NOH, COMe, or (un)substituted aryl; m = 0-1; n = 0-6] were prepared by cyclization and further reaction of 1-[2-(acylamino)phenyl]-1-phenylmethanone derivatives For example, 4-(5-chloro-2-hydroxyphenyl)-3-(2-hydroxyethyl)-6-(trifluoromethyl)-2(1H)-quinoline (II) was synthesized in a 5-step sequence starting with acylation of 1-[2-amino-5-(trifluoromethyl)phenyl]-1′-(5-chloro-2-methoxyphenyl)methanone (preparation given) with 3-carbomethoxypropionyl chloride (82%). Subsequent cyclization (100%), dehydration (78%), demethylation (86%), and reduction of the acid yielded II. II activated the cloned BK channel mSlo expressed in Xenopus oocytes, increasing whole cell outward (K+) BK-mediated currents > 200% at 20 μM. In an in vivo erectile function test on diabetic F-344 rats, II (0.1-1 mg/kg) significantly augmented intracavernous pressure/BP responses elicited by submaximal stimulation of the cavernous nerve. As BK channel openers, I are useful in the treatment of disorders which are responsive to the opening of the potassium channels, such as ischemia, stroke, convulsions, epilepsy, asthma, irritable bowel syndrome, migraine, traumatic brain injury, spinal cord injury, sexual dysfunction, and urinary incontinence. The experimental process involved the reaction of tert-Butyl (4-(trifluoromethyl)phenyl)carbamate(cas: 141940-37-6).Related Products of 141940-37-6

The Article related to arylquinolinone preparation potassium channel opener, quinolinone aryl preparation erectile dysfunction treatment, stroke treatment quinolinone aryl preparation, brain injury treatment quinolinone aryl preparation, sexual dysfunction quinolinone aryl preparation and other aspects.Related Products of 141940-37-6

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics